Park Avenue Securities LLC Astrazeneca PLC Transaction History

Park Avenue Securities LLC

$8.9 Billion
Q3 2024

A detailed history of Park Avenue Securities LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Park Avenue Securities LLC holds 62,601 shares of AZN stock, worth $4.17 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

62,601

Previous 69,390 9.78%

Holding current value

$4.17 Million

Previous $5.41 Million 9.89%

% of portfolio

0.05%

Previous 0.07%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	SELL	$76.67 - $87.62 $520,512 - $594,852	-6,789 Reduced 9.78%	62,601 $4.88 Million
Q2 2024 Jul 09, 2024	BUY	$66.81 - $80.83 $1.08 Million - $1.31 Million	16,161 Added 30.36%	69,390 $5.41 Million
Q1 2024 Apr 10, 2024	BUY	$61.03 - $69.57 $34,481 - $39,307	565 Added 1.07%	53,229 $3.61 Million
Q4 2023 Jan 10, 2024	BUY	$61.89 - $69.28 $471,973 - $528,329	7,626 Added 16.93%	52,664 $3.55 Million
Q3 2023 Oct 26, 2023	BUY	$64.85 - $71.7 $310,112 - $342,869	4,782 Added 11.88%	45,038 $3.05 Million
Q2 2023 Jul 14, 2023	BUY	$69.91 - $75.81 $1,747 - $1,895	25 Added 0.06%	40,256 $2.88 Million
Q1 2023 Apr 18, 2023	BUY	$63.15 - $71.6 $557,740 - $632,371	8,832 Added 28.13%	40,231 $2.79 Million
Q4 2022 Jan 24, 2023	BUY	$54.21 - $70.44 $139,102 - $180,749	2,566 Added 8.9%	31,399 $0
Q3 2022 Nov 01, 2022	BUY	$53.02 - $135.75 $350,144 - $896,493	6,604 Added 29.71%	28,833 $1.58 Million
Q2 2022 Jul 27, 2022	BUY	$59.26 - $71.14 $196,802 - $236,255	3,321 Added 17.56%	22,229 $1.47 Million
Q1 2022 Apr 29, 2022	BUY	$55.72 - $67.12 $74,609 - $89,873	1,339 Added 7.62%	18,908 $1.25 Million
Q4 2021 Apr 08, 2022	SELL	$54.02 - $63.83 $69,307 - $81,893	-1,283 Reduced 6.81%	17,569 $1.02 Million
Q3 2021 Oct 21, 2021	BUY	$55.56 - $60.79 $396,642 - $433,979	7,139 Added 60.95%	18,852 $1.13 Million
Q2 2021 Aug 05, 2021	BUY	$48.42 - $60.18 $133,251 - $165,615	2,752 Added 30.71%	11,713 $702,000
Q1 2021 Apr 28, 2021	BUY	$47.16 - $54.44 $85,784 - $99,026	1,819 Added 25.47%	8,961 $446,000
Q4 2020 Jan 20, 2021	BUY	$48.52 - $58.02 $138,961 - $166,169	2,864 Added 66.95%	7,142 $357,000
Q3 2020 Nov 03, 2020	SELL	$53.07 - $61.1 $26,588 - $30,611	-501 Reduced 10.48%	4,278 $234,000
Q2 2020 Jul 30, 2020	BUY	$43.1 - $55.31 $205,974 - $264,326	4,779 New	4,779 $253,000

Others Institutions Holding AZN

# of Institutions

1,359

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $207B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Park Avenue Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Park Avenue Securities LLC with notifications on news.

Account

Park Avenue Securities LLC Astrazeneca PLC Transaction History